Bromide

Bromide

SCHEMBL25318949

Br.CNC12CC(c3ccccc3)(C1)C2

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 known ✓ P31645 1/20 0.36
▸ GRIN2A known ✓ Q12879 1/20 0.35
▸ OPRM1 P35372 6/20 0.39
▸ OPRL1 P41146 5/20 0.39
▸ OPRK1 P41145 2/20 0.39
▸ PNMT P11086 1/20 0.39
▸ GRIN2D O15399 1/20 0.35
▸ GRIN3B O60391 1/20 0.35
▸ GRIN1 Q05586 1/20 0.35
▸ GRIN2B Q13224 1/20 0.35
▸ GRIN2C Q14957 1/20 0.35
▸ GRIN3A Q8TCU5 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ HTR2A P28223 2/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ MAOA P21397 1/20 0.32
▸ MAOB P27338 1/20 0.32
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27099133 0.98 OPRM1 (0.40) OPRM1OPRL1OPRK1PNMTSLC6A4
SCHEMBL21131203 0.78 PNMT (0.54) OPRM1OPRL1OPRK1PNMTSLC6A4
SCHEMBL20925330 0.76 PNMT (0.40) OPRM1OPRL1OPRK1PNMTGRIN2D
SCHEMBL30555211 0.75 PNMT (0.52) OPRM1OPRL1OPRK1PNMTGRIN2D
SCHEMBL3973946 0.75 PNMT (0.52) OPRM1OPRL1OPRK1PNMTGRIN2D
SCHEMBL21220171 0.71 MEN1 (0.40) PNMTMEN1KMT2AMAOB
SCHEMBL2710992 0.69 PNMT (0.46) OPRM1OPRL1OPRK1PNMTGRIN2D
SCHEMBL23141412 0.67 FAAH (0.56) MEN1KMT2A
SCHEMBL21220542 0.67 PNMT (0.62) PNMTGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL17582390 0.67 MAOB (0.46) OPRM1OPRL1OPRK1PNMTGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240043395-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING NEUROPORE THERAPIES, INC. 2024-02-08 — — US disclosed
EP-4217342-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING Neuropore Therapies, Inc. (US) 2023-08-02 — — EP disclosed
WO-2022067114-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING NEUROPORE THERAPIES, INC. (US) 2022-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240043395-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING TLR3, TLR6, TLR4 SLC6A4 3974/4885GRIN2A 133/4885OPRM1 1850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback